Longitudinal Validation of CIRC Technologies (NCT07081711)
๐ฉบ Plain-English Summary (8th-Grade Level)
Cardiovascular disease is the leading cause of death worldwide. Advanced cardiovascular imaging using Magnetic Resonance Imaging (MRI) has proven to be effective in providing gold standard myocardial tissue characterization. Moreover, the intrinsic advantage of MRI's lack of exposure to ionizing radiation is particularly beneficial. At the same time, blood work can be very useful in early detection of certain cardiomyopathy, such as amyloid. However, there is a lack of agreement of on which markers are the most sensitive. This multi-study will allow the unique opportunity to form a more comprehensive understanding for various cardiovascular diseases. The study team has developed novel cardiac MRI techniques that leverages endogenous tissue properties to reveal a milieu of deep tissue phenotypes including myocardial inflammation, fibrosis, metabolism, and microstructural defects. Among these phenotypes, myocardial microstructure has proven to be most sensitive to early myocardial tissue damage and is predictive of myocardial regeneration. In this study, the investigators aim to further study the importance of cardiac microstructure revealed by MRI in patient and healthy population and compare this novel technology with conventional clinical biomarkers.
Who can join: Review the eligibility criteria below.
Location: Cleveland Clinic โ Cleveland, Ohio
Age range: 18 Years
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (1 Sites)
- Cleveland Clinic โ Cleveland, Ohio
๐ Contact the Study Coordinator
Phone: (216) 445-6515
Email: CIRC@ccf.org
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cardiovascular Diseases
- The Jackson Heart Study of Cardiovascular Disease Among African Americans โ Jackson, Mississippi
- Using Big Data to Conduct Innovative Cardiovascular Clinical Trials โ Toronto, Ontario
- Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study โ Ottawa, Ontario
- Response of Cardiometabolic Biomarkers and Gut Microbiota to Walnut Consumption โ Davis, California
- Black Women's Life Experience On Cardiovascular Health Via Ongoing Monitoring โ Arlington, Texas
- Developing a Learning COmmunity to Increase eNgagemeNt and Enrollment in Cardiovascular Clinical Trials (CONNECT) โ Baltimore, Maryland
Explore by condition: All Cardiovascular Diseases clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.